novel car-ts to improve poor outcomes for patients with relapsed t-all post-transplant
Published 3 months ago • 44 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:59
novel car-t constructs being investigated for the treatment of all
-
2:32
phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
4:17
novel car t-cell therapies for hematological malignancies: exploring new targets
-
1:34
cctx-001: a novel car-t therapy for aml
-
0:49
novel targets for car-t therapy in mcl
-
2:12
expanding the reach of car-t
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
2:23
patient selection for autosct in hl & increasing cr rate before autosct with novel salvage regimens
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
4:44
optimizing lymphodepletion chemotherapy in car-t therapy recipients
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
-
4:23
novel strategies to optimize car t-cell therapy
-
1:12
novel all treatment strategies: car t-cells
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:16
evaluating the safety and efficacy of novel anti-cd7 universal car-t therapy in r/r t-all and t-lbl